| 0.22 Data as of May 24 | +0.012 / +5.77%Today’s Change | 0.02 Today|||52-Week Range 0.31 | +4.76% Year-to-Date |
| Previous close | 0.21 |
| Today’s open | 0.22 |
| Day’s range | 0.21 - 0.22 |
| Volume | 1,975,869 |
| Average volume (3 months) | 3,628,623 |
| Market cap | $160.9M |
| Dividend yield | -- |
| Earnings growth (last year) | +66.67% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +91.43% |
| P/E ratio | NM |
| Price/Sales | 78.90 |
| Price/Book | 188.03 |
| Today’s change | Today’s % change | |
|---|---|---|
| TTPHTetraphase Pharmaceu... | -0.04 | -0.51% |
| OMEROmeros Corp | +0.22 | +4.33% |
| OGXIOncoGenex Pharmaceut... | +0.09 | +0.85% |
| OMTHOmthera Pharmaceutic... | -0.33 | -4.65% |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $1.9M |
| Annual profit (last year) | -$7.2M |
| Net profit margin | -385.55% |
Sector Technology Services |
Industry Information Technology Services |
Chairman, President & Chief Executive Officer James A. Hayward, PhD |
Chief Financial Officer Kurt H. Jensen |
Corporate headquarters Stony Brook, New York |
